North America Leads the Adult Non Hodgkin Lymphoma Treatment Market
North America leads the Adult Non Hodgkin Lymphoma Treatment Market, driven by high NHL incidence, advanced oncology infrastructure, and rapid adoption of innovative therapies. The US has one of the highest NHL incidence rates globally, and its healthcare system supports rapid adoption of novel treatments, including CAR-T therapies and bispecific antibodies. Europe follows closely, supported by...
0 Commenti 0 condivisioni 3 Views 0 Anteprima